157 related articles for article (PubMed ID: 29872311)
1. The methylation profiles of PRDM promoters in non-small cell lung cancer.
Tan SX; Hu RC; Xia Q; Tan YL; Liu JJ; Gan GX; Wang LL
Onco Targets Ther; 2018; 11():2991-3002. PubMed ID: 29872311
[TBL] [Abstract][Full Text] [Related]
2. Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells.
Tan SX; Hu RC; Liu JJ; Tan YL; Liu WE
Int J Clin Exp Pathol; 2014; 7(5):2305-11. PubMed ID: 24966940
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma.
Tan SX; Hu RC; Tan YL; Liu JJ; Liu WE
Tumour Biol; 2014 May; 35(5):4509-16. PubMed ID: 24395656
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
[TBL] [Abstract][Full Text] [Related]
5. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
6. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
[TBL] [Abstract][Full Text] [Related]
7. PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.
Sorrentino A; Federico A; Rienzo M; Gazzerro P; Bifulco M; Ciccodicola A; Casamassimi A; Abbondanza C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347759
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer.
Teng JJ; Zhao WJ; Zhang XL; Zhao DK; Qiu XY; Chen XD; Yang L
J Cancer; 2021; 12(22):6921-6930. PubMed ID: 34659579
[No Abstract] [Full Text] [Related]
9. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.
Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G
Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
11. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
12. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
Song H; Yi J; Zhang Y; Wang R; Chen L
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Hypermethylation at Sites -86 to 226 of DAB2 Gene in Non-Small Cell Lung Cancer.
Li C; Chen J; Chen T; Xu Z; Xu C; Ding C; Wang Y; Lei Z; Zhang HT; Zhao J
Am J Med Sci; 2015 May; 349(5):425-31. PubMed ID: 25719979
[TBL] [Abstract][Full Text] [Related]
14. Identification of DLC-1 expression and methylation status in patients with non-small-cell lung cancer.
Feng H; Zhang Z; Wang X; Liu D
Mol Clin Oncol; 2016 Feb; 4(2):249-254. PubMed ID: 26893870
[TBL] [Abstract][Full Text] [Related]
15. Role of PRDM16 and its PR domain in the epigenetic regulation of myogenic and adipogenic genes during transdifferentiation of C2C12 cells.
Li X; Wang J; Jiang Z; Guo F; Soloway PD; Zhao R
Gene; 2015 Oct; 570(2):191-8. PubMed ID: 26071185
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
[TBL] [Abstract][Full Text] [Related]
17. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of
Ma H; Chen X; Hu H; Li B; Ying X; Zhou C; Zhong J; Zhao G; Duan S
Oncol Lett; 2018 Jun; 15(6):9017-9024. PubMed ID: 29805634
[TBL] [Abstract][Full Text] [Related]
19. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
Wang SH; Liu NH; Wang J; Bai H; Mao L
Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.
Kim TH; Moon JY; Kim SH; Paik SS; Yoon HJ; Shin DH; Park SS; Sohn JW
J Korean Med Sci; 2015 Feb; 30(2):155-61. PubMed ID: 25653486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
